维普期刊资源整合服务平台（V6.5）

375篇 您的检索式：作者名="Riely"

选中清除导出查看参考文献查看引证文献引用追踪共19页首页上一页第1页下一页末页 /19 跳转

	题名	作者	年代	出处	被引量
1	International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma显示文摘	William D. Travis Elisabeth Brambilla Masayuki Noguchi Andrew G. Nicholson Kim R. Geisinger Yasushi Yatabe David G. Beer Charles A. Powell Gregory J. Riely Paul E. Van Schil Kavita Garg John H. M. Austin Hisao Asamura Valerie W. Rusch Fred R. Hirsch Giorg	2011	Journal of Thoracic Oncology2011，，2：	4
2	Local Therapy with Continued EGFR Tyrosine Kinase Inhibitor Therapy as a Treatment Strategy in EGFR-Mutant Advanced Lung Cancers That Have Developed Acquired Resistance to EGFR Tyrosine Kinase Inhibitors显示文摘	Helena A. Yu Camelia S. Sima James Huang Stephen B. Solomon Andreas Rimner Paul Paik M. Catherine Pietanza Christopher G. Azzoli Naiyer A. Rizvi Lee M. Krug Vincent A. Miller Mark G. Kris Gregory J. Riely	2013	Journal of Thoracic Oncology2013，，3：	2
3	Clinical definition of ac-quired resistance to epidermal growth factor receptor tyrosine ki-nase inhibitors in non-small-cell lung cancer显示文摘	Jackman D Pao W Riely G J		0，，2：	1
4	Genetic and genomie analysis in model legumes bring Nodfactor signaling to center stage显示文摘	Riely B K Ané J M Penmetsa R V	2004	Current Opinion in Plant Biology2004，，7：	1
5	Phase II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired re- sistance to erlotinib显示文摘	Riely J Janjigian YY Azzoli CG	2010	J Clin Oncol2010，28，：	1
6	Surgery and obstructive sleep apnea:lougteam clinical outcome显示文摘	Riely RW Powell NB Li KK	2000	Otolaryngol Head Neck Surg2000，122，：	1
7	International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma显示文摘	William D. Travis Elisabeth Brambilla Masayuki Noguchi Andrew G. Nicholson Kim R. Geisinger Yasushi Yatabe David G. Beer Charles A. Powell Gregory J. Riely Paul E. Van Schil Kavita Garg John H. M. Austin Hisao Asamura Valerie W. Rusch Fred R. Hirsch Giorg	2011	Journal of Thoracic Oncology2011，，2：	1
8	Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer显示文摘	Jackman D Pao W Riely GJ ct al	2010	J Clin Oncol2010，28，2：	1
9	KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib and erlotinib显示文摘	Pao W Wang TY Riely GJ	2005	PLoS Med2005，，：	1
10	Vascular endothelial growth factor trap in non - small cell lung cancer 显示文摘	Riely GJ Miller VA	2007	Clin Cancer Res2007，13，15：	1
11	KRAS mutations andprimary resistance of lung adenocarcinomas to gefitinib or erlotinib显示文摘	Pao W Wang TY Riely GJ et a1		0，，01：	1
12	Initial phase Ⅱ results with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC):PROFILE 1005显示文摘	Crino L Kim D Riely GJ		0，，：	1
13	Activity and safety of crizotinib in patients with ALK -positive non-small-cell lung cancer: updated results from a phase 1 study显示文摘	D Ross Camidge Yung-Jue Bang Eunice L Kwak A John Iafrate Marileila Varella-Garcia Stephen B Fox Gregory J Riely Benjamin Solomon Sai-Hong I Ou Dong-Wan Kim Ravi Salgia Panagiotis Fidias Jeffrey A Engelman Leena Gandhi Pasi A J?nne Daniel B Costa Geoffrey	2012	Lancet Oncology2012，，10：	1
14	KRAS mutations:an old oncogene becomes a new predictive biomarker显示文摘	Riely GJ Ladanyi M	2008	J Mol Diagn2008，10，6：	1
15	Initial phase II resultswith Crizotinib in advanced ALK-positive non-small celllung cancer(NSCLC):PROFILE 1005 显示文摘	Crino L Kim Ds Riely G J	2011	J Clin Oncol2011，29，15：	1
16	Lung adenocarcinoma:modifica-tion of the 2004 WHO mixed subtype to include the major histologicsubtype suggests correlations between papillary and micropapillary ade-nocarcinoma subtypes,EGFR mutations and gene expression analysis显示文摘	Motoi N Szoke J Riely G J	2008	Am J Surg Pathol2008，32，6：	1
17	Clinical course of patients withnon-small cell lung cancer and epidermal growth factor receptorexon 19 and exon 21 mutations treated with gefitinib or erlotinib显示文摘	Riely GL Pao W Plam D	2006	Clin Cancer Res2006，12，31：	1
18	Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib 显示文摘	Miller VA Riely GJ Zakowski MF	2008	J Clin Oncol2008，26，9：	1
19	Molecular eharacteristies of hronehioloalveolar carcinmna and adenocarcinoma, bronchioloalve- olar carcinomasubtype, predict response to erlotinib 显示文摘	Miller VA Riely GJ Zakowski MF	2008	J Clin Oncol2008，26，9：	1
20	Clinical definition of acquired resistance to epidermal growth factor receptor ty- rosine kinase inhibitors in non-small-cell lung cancer显示文摘	Jackman D Pao W Riely GJ	2010	J Clin Oncol2010，28，2：	1

返回顶部每页显示：

共19页首页上一页第1页下一页末页 /19 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示